Pharma News

Scroll Down To Discover

Swiss WorldCargo has finalized preparation for transport of COVID-19 vaccines

For the past six months, Swiss WorldCargo has prepared for the distribution of COVID-19 vaccines. Beginning in summer 2020, the company set up an internal task force to analyse the potential for shipping COVID-19 vaccines throughout the world. The task force, comprised of team members from different divisions, has closely analysed how Swiss WorldCargo’s aircraft, network and capacity to and from Switzerland, can best support these global shipments.

Recently, the company has successfully carried out first shipments. These have proven that the company can handle complex regulatory and customer necessities, including temperature, cold-chain and timing requirements.

As a leading carrier of pharmaceutical and care-intensive goods, Swiss WorldCargo has a rich history of successful and speedy delivery of pharmaceutical products, including vaccines. This long-standing expertise is based on its well-trained staff, as well as the strengths of its hub and ground handling partners. Swiss WorldCargo’s organization is CEIV Pharma-certified. Swiss WorldCargo’s hub in Zurich, operated by Cargologic, is IATA CEIV Pharma-certified and Swissmedic GDP-compliant, as recognized by the Swiss authorities.

"The next few months present a significant challenge for the entire air cargo and logistics industry," said Christian Wyss, Head of Quality & Services at Swiss WorldCargo, and leader of the Swiss WorldCargo Vaccine Transport task force. "However, based on our extensive experience carrying out complex pharmaceutical shipments, Swiss WorldCargo is well-positioned to help ship COVID-19 vaccines, to, from and through Switzerland to a variety of global destinations."

Prev Post cargo.one raises $42 million in Series B fund...
Next Post First ATR 72-600F Aircraft Delivered to FedEx...
You may also like

Please subscribe in order to view the E-Magazine

or

You can login to your account.

Login
or

You can subscribe to get the access.

Subscribe